BPC-157: Benefits, Dosage, Side Effects, and How to Get It in 2026

BPC-157 is a synthetic peptide studied for tendon, ligament, muscle, and digestive-tract repair. Its name stands for Body Protection Compound, and most of what researchers know so far comes from laboratory and animal studies.

What is BPC-157?

BPC stands for Body Protection Compound. BPC-157 is a lab-made peptide based on a sequence associated with a larger protective compound found in gastric juice. It contains 15 amino acids, which is why researchers also call it a pentadecapeptide.

The finished peptide is synthetic. It concentrates one short amino-acid sequence into a form researchers can study on its own. Product descriptions may identify BPC-157 as a free base or an acetate salt. Those are different active ingredients, so the exact form matters when comparing products or reading a study.

Benefits and uses researchers are exploring

BPC-157 is best known for recovery. Interest centers on tissues that can be slow to heal, including tendons, ligaments, and muscles. Its connection to gastric juice also led researchers to explore the stomach and intestinal lining.

Here is where the research is concentrated:

• Tendons and ligaments. A tendon-cell and rat study examined cell movement, collagen organization, blood supply, and the strength of healing tissue.
• Muscle recovery. Animal injury models examine blood-vessel growth, inflammation, and restoration of damaged muscle.
• Digestive health. Studies in animals cover ulcers, inflammatory injury, intestinal damage, and the effects of NSAID medicines on the digestive tract.
• Inflammation and tissue protection. Laboratory research has explored inflammatory signaling in bone, skin, nerves, and blood vessels.

BPC-157 users often describe changes in pain, movement, return to training, or digestive comfort. Those experiences explain much of its popularity, while structured measurements make individual recovery stories easier to interpret.

Most published results come from cells and animals. A controlled Phase 2 study is now testing BPC-157 alongside rehabilitation in adults with acute hamstring strains.

How does BPC-157 work?

Researchers do not point to one single pathway. Instead, BPC-157 appears to influence several parts of the repair process at once.

• Angiogenesis means growing new blood vessels. Damaged tissue needs blood flow to deliver oxygen and building materials, and BPC-157 has affected this process in preclinical studies.
• Fibroblasts are cells that help build collagen and the structural framework of tendons, ligaments, skin, and other tissues. BPC-157 has changed how tendon fibroblasts move and respond in laboratory work.
• Growth-hormone signaling helps coordinate tissue growth and repair. In rat tendon cells, BPC-157 increased growth-hormone receptor expression, making those cells more responsive to growth hormone in the experiment.
• Nitric oxide helps regulate blood-vessel tone and circulation. BPC-157 interacts with this signaling system in animal and laboratory models.

Together, these findings explain why BPC-157 attracts attention for recovery. They are proposed mechanisms, and the recruiting hamstring trial is designed to test whether they translate into faster structural and functional recovery in people.

What has human research found?

Human research is just getting started. FDA's 2026 evidence review found very limited clinical information. That makes it helpful to separate what scientists have observed in cells and animals from the questions now being tested in people.

Dosage, injections, and capsules

Reported BPC-157 protocols commonly cite 200–500 mcg once or twice daily for four to six weeks. Subcutaneous injection is the form most often described, sometimes near the injured area. These are reported practice patterns rather than a standardized dose.

Other forms include intramuscular injections, capsules, oral liquids, nasal sprays, and topical products. A pharmacokinetic study in rats and dogs measured BPC-157 after intravenous and intramuscular dosing, including how much reached circulation. Route changes where the peptide is delivered, its absorption, and its exposure to digestive enzymes. Research or experience with one route does not automatically describe another.

Reconstitution means mixing a vial of freeze-dried peptide with the specified amount of bacteriostatic water. Enter a prescribed target dose in the peptide dosage calculator to convert the dose into syringe units. Follow the handling steps in the reconstitution guide.

Side effects and safety

A preclinical safety program in mice, rats, rabbits, and dogs reported no serious toxicity in its single-dose and repeat-dose experiments. That finding is one reason BPC-157 is often described as well tolerated. It records what happened in those animals rather than establishing a human safety profile.

People and clinics report injection-site reactions, nausea, fatigue, and lightheadedness. FDA's review also includes reports of shortness of breath and changes in skin or gum color. Reports like these help identify concerns, but they do not show how often an effect occurs.

The product itself is part of the safety question. Strength, purity, storage, and sterility can vary, especially with products sold online. FDA has also raised concerns about immune reactions, peptide impurities, and inconsistent characterization of the active ingredient.

Making sense of BPC-157 before-and-after stories

A useful recovery story includes more than two photos. Look for the original diagnosis, injury grade, rehabilitation plan, activity changes, and other treatments. Useful stories also measure strength, movement, pain, or return to sport.

Timelines also vary by tissue. A muscle strain, tendon problem, and ligament injury do not heal on the same schedule. Those details determine whether a recovery story is relevant to a particular injury.

How to get BPC-157 in 2026

BPC-157 and TB-500

BPC-157 is frequently paired with TB-500 for recovery. BPC-157 research focuses on blood vessels, fibroblasts, and local repair. TB-500 is associated with cell movement and broader soft-tissue regeneration.

Reported schedules and the assigned role of each peptide are collected in the BPC-157 and TB-500 stack guide. The BPC-157 vs TB-500 comparison distinguishes the two options. Other healing and recovery peptides include KPV.

Blood work and recovery tracking

BPC-157 does not have a direct blood marker. For a tendon or muscle injury, the most useful measures are usually pain, movement, strength, activity, and imaging when clinically indicated.

Blood work can still provide a baseline for broader safety and response markers. An hs-CRP test tracks systemic inflammation, although it cannot identify the injured tissue. A comprehensive metabolic profile adds liver, kidney, glucose, and electrolyte context.

In reported practice, people often test before starting and repeat those markers after four to six weeks. That timing creates an early comparison during a commonly described recovery cycle. Clinicians may use a different schedule based on the injury, health history, and markers being followed.

Lab results add health context, while the injury assessment shows how the tissue is recovering.